申请人:Merck & Co., Inc.
公开号:US06156895A1
公开(公告)日:2000-12-05
An improved process using chiral hydrogenation is described for the synthesis in high yields of a 4-protected-(S)-piperazine-2-tert-butylcarboxamide, an intermediate for an HIV protease inhibitor.
使用手性氢化的改进过程,用于高产率合成4-保护-(S)-哌嗪-2-叔丁基甲酰胺,这是HIV蛋白酶抑制剂的中间体。